CUREVAX

CureVax is an emerging cancer treatment method in which a patient’s tumor cells are sampled, grown in the laboratory, and burst open in a very specific way in order to expose that specific cancer’s vulnerabilities. These processed shreds of the tumor cells are then injected back into the patient, stimulating his or her immune system to attack the cancer. A virus-lysed tumor cell vaccine is an active immunotherapeutic agent against tumors in patients. Tumor cells are removed from a patient, t... he cells are cultured in the laboratory and infected with live vaccinia virus—the active component of the vaccine that eradicated smallpox. During incubation, viral oncolysis occurs, in which the virus enters the tumor cells and breaks them open, spilling their contents, in a process known as lysis. The resulting viral oncolysate has lost the ability to grow as a tumor, but can be recognized by the patient’s immune system as the tumor. After extraction and processing, the viral oncolysate may be injected back into the patient to stimulate the immune response.

#SimilarOrganizations #People #Financial #Website #More

CUREVAX

Industry:

Biotechnology Health Care Pharmaceutical

Founded:

2006-01-01

Address:

Brooklyn, New York, United States

Country:

United States

Website Url:

http://www.curevax.com

Total Employee:

Status:

Active

Total Funding:

9.87 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Mobile Non Scaleable Content Nginx Euro